Quick Answer
Bone Biologics Corp reported Net Income of -$3.11 million for fiscal year 2025.
Bone Biologics Corp Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$3.11M | +24.4% |
| 2024 | -$4.11M | +54.0% |
| 2023 | -$8.95M | -502.8% |
| 2022 | -$1.48M | +7.8% |
| 2021 | -$1.61M | +11.7% |
| 2020 | -$1.82M | +46.7% |
| 2019 | -$3.42M | +22.7% |
| 2018 | -$4.43M | +37.2% |
| 2017 | -$7.05M | +72.8% |
| 2016 | -$25.88M | -86.5% |
| 2015 | -$13.88M | -213.6% |
| 2014 | -$4.42M | -308.8% |
| 2013 | -$1.08M | -20687.6% |
| 2013 | -$5.2K | +7.5% |
| 2012 | -$5.6K | -14.5% |
| 2011 | -$4.9K | -36.8% |
| 2010 | -$3.6K | +65.0% |
| 2009 | -$10.3K | +22.9% |
| 2008 | -$13.3K | +38.9% |
| 2007 | -$21.8K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$666.7K | +29.1% | +10.0% |
| June 30, 2025 | -$740.5K | +5.5% | +27.2% |
| March 31, 2025 | -$1.02M | -17.5% | -8.1% |
| September 30, 2024 | -$941.0K | +51.0% | -20.1% |
| June 30, 2024 | -$783.7K | +55.7% | +9.5% |
| March 31, 2024 | -$866.0K | +76.7% | +54.9% |
| September 30, 2023 | -$1.92M | -57.4% | -8.5% |
| June 30, 2023 | -$1.77M | -277.0% | +52.3% |
- Bone Biologics Corp showed an increase of +24.4% in Net Income compared to the prior fiscal year.
- Over the 2007–2025 period, Bone Biologics Corp’s net income has declined by 14146.4% (from -$21.8 thousand to -$3.11 million).
- The most recent figure is from Bone Biologics Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: